Inflammasomes as a Prognostic Marker and Possible Therapeutic Target in Multiple Sclerosis: A Rapid Review of the Literature. (2023). Principles and Practice of Clinical Research, 9(2). https://doi.org/10.21801/ppcrj.2023.92.7